DTC Study Shows Limited Risk Statement Works, But Will Pharma Ad Practices Change?

Viewers retain more risks and benefits in DTC ads showing only limited risk information, but experts predict it may not result in substantial change right away.

Advertising

Industry soon could be relieved from reading all the risks of its drugs in its TV advertising, thanks to an FDA study that found that listing only the most serious of them resulted in better recall.

Preliminary results of a study comparing a limited statement of risks to the traditional full statement in television ads found that patients recalled more of the drug's serious risks from...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Marketing & Advertising

More from Compliance